BioAge Labs BIOA
NASDAQ BIOA
$6.81 -0.28 (-3.95%)
As of: Oct 1, 2026 · 3:28 PM EDT

BioAge Labs (BIOA) Preferred Stock Liabilities (2023 - 2024)

Updated

BioAge Labs (BIOA) reported Preferred Stock Liabilities of $342.83 million for Q2 2024, unchanged from the prior quarter.

Analysis

BioAge Labs (BIOA) Preferred Stock Liabilities (2023 - 2024) Analysis & Trends

At the end of FY2023, BioAge Labs posted Preferred Stock Liabilities of $132.72 million.

  • Per Business Quant data, the three quarters before Q2 2024 came in at $342.83 million (Q1 2024), $132.72 million (Q4 2023) and $132.72 million (Q3 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 BioAge Labs 324.56 Mn 324.56 Mn -14.23 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 342.83 Mn
Mar 31, 2024 342.83 Mn
Dec 31, 2023 132.72 Mn
Sep 30, 2023 132.72 Mn
API Access

BioAge Labs Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=BIOA&period=max&api_key=YOUR_API_KEY